Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Tumor-Agnostic 5CNS 5Head & Neck 2Sarcoma 1Gynecologic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Melanoma 15Carcinoma, Basal Cell 6Skin Neoplasms 5Recurrence 2Neoplasm Metastasis 2Uveal Melanoma 1Neoplasms 1Lentigo Maligna Melanoma (Head or Neck) 1Eyelid Squamous Cell Carcinoma 1Eye Neoplasms 1Eye Diseases 1Death 1Carcinoma, Squamous Cell 1Carcinoma, Merkel Cell 1Advanced Head and Neck Squamous Cell Carcinoma 1

Interventions

pembrolizumab 40Nivolumab 18trametinib 13Cyclophosphamide 13dabrafenib 11Vemurafenib 10Interleukin-2 10Ipilimumab 9fludarabine 7Docetaxel 7fludarabine phosphate 6cemiplimab 6Paclitaxel 6Cisplatin 6Carboplatin 6atezolizumab 5Radiotherapy 5Drug Therapy 5Dacarbazine 5Blood Specimen Collection 5Biopsy 5poly ICLC 4binimetinib 4Therapeutics 4Psychiatric Rehabilitation 4sotigalimab 3montanide ISA 51 3encorafenib 3cobimetinib 3budigalimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Surgical Procedures, Operative × Dermatologic × Clear all
NCT00707161 2017-03-31

Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma

University of Utah

Phase 2 Terminated
6 enrolled 4 charts
Dermatologic

Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡